Portugal has a robust agricultural background, so selecting our cultivation site in the Alentejo region of Portugal was not by chance. A region of vast open countryside with undulating plains and rich fertile soil, blessed with California-like weather, ample sunshine and a favorable climate, ideal conditions for outdoor cannabis cultivation.
Portugal also has highly qualified human resources that play a major role in leveraging the pharmaceutical R&D in the country and as a member of the European Union gives Symtomax clear, tariff free and unobstructed access to all member states markets where medical cannabis is legal.
ADVANCING ALTERNATIVE AND EFFECTIVE PRODUCTS TO IMPROVE THE HEALTH AND
WELL-BEING OF PEOPLE.
Symtomax was established in 2017 with a commitment to advancing alternative and effective products to improve the health and well-being of people. Our team of professionals has decades of combined experience in cannabis cultivation, adhering to strict procedural and environmental protocols to maximise purity, quality and consistency.
We have built partnerships that will improve consumers’ access to the best products around the world as well as invested in industry-leading research and development. This strategy allows Symtomax to use leading technology to develop high-quality and technologically advanced cannabis products that can be sold around the world.
MEET THE TEAM
We are a motivated, committed and innovative team, together across disciplines and research areas in a pioneering, challenging and dynamic environment. We understand that our activities must be geared towards excellence and sustainable development, something we can only achieve thanks to our most important asset: our workforce.